| Phloridzin docosahexaenoate |
Influence on cell viability |
MTS |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell viability |
MTS |
25.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell viability |
MTS |
50.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell viability |
MTS |
75.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell viability |
MTS |
100.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell viability |
CellTiter-Glo luminescent assay |
100.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell proliferation |
Flow cytometry |
30.00 µM |
K562 |
Homo sapiens |
|
|
|
| Phloridzin docosahexaenoate |
Influence on cell apoptosis |
Flow cytometry- annexin V binding and propidium iodide staining |
50.00 µM |
K562 |
Homo sapiens |
|
|
|
